Steroid Therapy for Chronic Bronchitis

Introduction to Steroid Therapy

The American Thoracic Society recommends a short course (10-15 days) of systemic corticosteroid therapy for acute exacerbations of chronic bronchitis, with both IV therapy for hospitalized patients and oral therapy for ambulatory patients proven effective 1, 2, 3

Systemic corticosteroids (oral or IV) for 10-15 days are recommended with substantial evidence supporting their use for acute exacerbations of chronic bronchitis, improving treatment outcomes including lung function and reducing treatment failure rates 4, 5
Corticosteroids improve lung function (FEV1) and reduce treatment failure rates in patients with acute exacerbations of chronic bronchitis 5
A 2-week course of corticosteroids was equivalent to an 8-week course, suggesting shorter durations are preferable to minimize side effects in patients with acute exacerbations of chronic bronchitis 1

The American College of Chest Physicians recommends that oral corticosteroids should NOT be used for long-term maintenance therapy in stable chronic bronchitis, as there is no evidence of benefit and the well-known side effects preclude their long-term use 6, 7

For patients with severe or very severe airflow obstruction (FEV1 <50% predicted) or frequent exacerbations of chronic bronchitis, inhaled corticosteroid therapy should be offered, as it has been shown to reduce exacerbation rates and cough in long-term trials 6
Combined therapy with a long-acting β-agonist and an inhaled corticosteroid has been shown to reduce exacerbation rates and cough in long-term trials for patients with chronic bronchitis 1, 8
For patients with chronic bronchitis without severe airflow limitation, bronchodilators (short-acting β-agonists or ipratropium bromide) should be the first-line therapy, as they have been shown to improve symptoms and lung function 4

Corticosteroids can cause significant side effects, especially with prolonged use, including growth suppression in children 4, osteoporosis 3, hyperglycemia 3, and immunosuppression 3

For acute exacerbations, the recommended treatment algorithm includes starting with short-acting bronchodilators (β-agonists or anticholinergics), adding systemic corticosteroids for 10-15 days, and considering antibiotics if bacterial infection is suspected 4, 5, 8
For stable chronic bronchitis, the recommended treatment algorithm includes using short-acting bronchodilators as first-line therapy, adding inhaled corticosteroids for patients with FEV1 <50% or frequent exacerbations, and considering combination therapy with long-acting β-agonist plus inhaled corticosteroid for persistent symptoms 1, 4, 6, 8